Tag Archives: MDR-TB

TB Alliance Sublicenses Promising Anti-Tuberculosis Drug from the Medicines Patent Pool

Herman Opondo On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a licensing agreement for the clinical development of sutezolid, an antibiotic drug candidate which demonstrated encouraging results in early studies. The sublicense pertains to the development of sutezolid in combination with other TB drugs and follows the MPP’s license for

Tuberculosis Critical Group of Bacteria, needs new Antibiotics ─ TB Alliance tells WHO

By Herman Opondo TB Alliance and the broader TB community urge that The World Health Organization (WHO) was on Wednesday urged to add Mycobacterium tuberculosis to the critical group within the list of drug-resistant bacteria identified as urgent priorities for research and development. “The absence of TB from this list is shocking,” said Mel Spigelman,

Nigeria, South Africa immensely contribute to global TB disease burden

By Henry Opondo Nigeria and South Africa in combination with Asian countries of Indonesia, China and Pakistan contributed to 60% of all tuberculosis disease burden in 2015, a new WHO report on TB reveals. According to the report, there were an estimated 10.4 million new TB cases worldwide and that the burden is higher than

Top